-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
NeuroBo Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2016 to Q3 2024.
- NeuroBo Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -189 %, a 256% decline year-over-year.
- NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2023 was -59.4 %, a 48.5% increase from 2022.
- NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2022 was -115 %, a 18.2% increase from 2021.
- NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2021 was -141 %, a 56.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)